XKRX
161890
Market cap1.05bUSD
Dec 05, Last price
65,500.00KRW
1D
0.31%
1Q
-13.59%
Jan 2017
-0.46%
IPO
132.68%
Name
Kolmar Korea Co Ltd
Chart & Performance
P/E
17.17
P/S
0.63
EPS
3,815.88
Div Yield, %
—
Shrs. gr., 5y
0.64%
Rev. gr., 5y
9.74%
Revenues
2.45t
+13.75%
Net income
90.07b
+1,634.92%
CFO
215.38b
+91.89%
Dividend
Dec 27, 2023600 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kolmar Korea Co., Ltd. researches, develops, produces, and sells beauty and health products in South Korea and internationally. It offers various cosmetic products, including skin care, makeup, baby, hair care, and body care products, as well as perfume, functional cosmetics, and qusi drugs. The company also provides prescription, over-the-counter, and bioequivalent drugs; drugs for dermatology and circulatory system; ointment and external, and oral solutions; and oral solids. In addition, it offers health functional food comprising health supplements; ingredients; special purpose food; and individually recognized health supplements. The company was founded in 2012 and is headquartered in Sejong, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||